Aluminum and Alzheimer's Disease: Perspectives for a Cytoskeletal Mechanism

References

• Curran J. W., Morgan W. M., Hardy A. M., Jaffe H. W., Darrow W. W., Dowoll W. R. The epidemiology of AIDS: current status and future prospects. Science 1985; 229: 1352
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. 1984; 1323, Alzheimer's disease: Report of the Secretary's Task Force on Alzheimer's Disease, Publication no. (ADM) 84
   Google Scholar
• Wisniewski H. M., Iqbal K. Ageing of the brain and dementia. Trends Neurosci. 1980; 226
   Web of Science ®Google Scholar
• DeBoni U., McLachlan Crapper D. R. Senile dementia and Alzheimer's disease: a current view. Life Sci. 1980; 27: 1
   PubMed Web of Science ®Google Scholar
• Arie T. Prevention of mental disorders of old age. J. Am. Geriair. Soc 1984; 32: 460
   PubMed Web of Science ®Google Scholar
• Cummings J. L., Benson D. F. Subcortical dementia: review of an emerging concept. Arch. Neurol. 1984; 41: 874
   PubMed Web of Science ®Google Scholar
• Huff F. J., Corkin S. Recent advances in the neuropsychology of Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 1984; 8: 643
   PubMed Web of Science ®Google Scholar
• McLachlan Crapper D. R., Dalton A. J., Galin H., Schlotterer G., Daicar E. Alzheimer's disease: clinical course and cognitive disturbances. Acta Neurol. Scand. Suppl. 1984; 99: 83
   PubMedGoogle Scholar
• Duffy F. H., Albert M. S., McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann. Neurol. 1984; 16: 439
   PubMed Web of Science ®Google Scholar
• Jenike M. A., Albert M. S. The deamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type. J. Am. Geriair. Soc. 1984; 32: 441
   PubMed Web of Science ®Google Scholar
• Huff F. J. Alzheimer's disease: advances in basic research and therapies. Neurobiol. Aging 1984; 5: 157
   PubMed Web of Science ®Google Scholar
• Mann D. M. A., Yates P. O., Marcyniuk B. Alzheimer's presenile dementia, senile dementia of the Alzheimer's type, and Down's syndrome in middle age all form an age related contiuum of pathological changes. J. Pathol. 1984; 143: 314A
   Web of Science ®Google Scholar
• Berg L. Does Alzheimer's disease represent an exaggeration of normal aging?. Arch. Neurol. 1985; 42: 737
   PubMedGoogle Scholar
• Heyman A., Wilkinson W. E., Stafford J. A., Helms M. J., Sigmon A. A., Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann. Neurol. 1984; 15: 335
   PubMed Web of Science ®Google Scholar
• Breitner J. C. S., Folstein M. F. Familial nature of Alzheimer's disease. N. Engl. J. Med. 1984; 311: 192
   PubMedGoogle Scholar
• McLachlan Crapper D. R., Lewis P. N. Alzheimer's disease: errors in gene expression. Can. J. Neurol. Sci. 1985; 12: 1
   PubMed Web of Science ®Google Scholar
• Heston L. L. Down's syndrome and Alzheimer's dementia: defining an association. Psychiatr. Dev. 1984; 4: 287
   Google Scholar
• Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 1985; 17: 278
   PubMed Web of Science ®Google Scholar
• Ulrich J. Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of the Alzheimer's type. Ann. Neurol. 1985; 17: 273
   PubMed Web of Science ®Google Scholar
• Miller F. D., Hicks S. P., D'Amato C. J., Landis J. R. A descriptive study of neuritic plaques and neurofibrillary tangles in an autopsy population. Am. J. Epidemiol. 1984; 120: 331
   PubMed Web of Science ®Google Scholar
• Glenner G. G. Alzheimer's disease: the commonest form of amyloidosis. Arch. Pathol. Lab. Med. 1983; 107: 281
   PubMed Web of Science ®Google Scholar
• Glenner G. C., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984; 120: 885
   PubMed Web of Science ®Google Scholar
• Wong C. W., Quaranta V., Glenner G. G. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc. Natl. Acad. Sci. 1985; 82: 8729
   PubMed Web of Science ®Google Scholar
• Gorevic P. D., Goni F., Pons-Estel B., Alvarez F., Peress N. S., Frangione B. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immu-nohistological studies. J. Neuropathol. Exp. Neurol. 1986; 45: 647
   PubMed Web of Science ®Google Scholar
• Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down's syndrome. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 4245
   PubMed Web of Science ®Google Scholar
• Masters C. L., Multhaup G., Simms G., Pottgiesser J., Martins R. N., Beyreuther K. Neuronal origin of cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 1985; 4: 2757
   PubMed Web of Science ®Google Scholar
• Wisniewski H., Terry R. D., Hirano A. Neurofibrillary pathology. J. Neuropathol. Exp. Neurol. 1970; 29: 163
   PubMed Web of Science ®Google Scholar
• Wisniewski H. K., Narang H. K., Terry R. D. Neurofibrillary tangles of paired helical filaments. J. Neurol. Sci. 1976; 27: 173
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M., Mere P. A., Iqbal K. Infrastructure of paired helical filaments of Alzheimer's neurofibrillary tangle. J. Neuropathol. Exp. Neurol. 1984; 43: 643
   PubMed Web of Science ®Google Scholar
• Bray D., Gilbert D. Cytoskeletal elements in neurons. Ann. Rev. Neurosci. 1981; 4: 505
   PubMed Web of Science ®Google Scholar
• Ihara Y., Abraham C., Selkoe D. J. Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature (London) 1983; 304: 727
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I., Iqbal K., Tung Y. C., Wang G. P., Wisniewski H. M. Alzheimer paired helical filaments: cross reacting polypeptide/s normally present in brain. Acta Neuropathol. (Berlin) 1985; 66: 52
   PubMed Web of Science ®Google Scholar
• Wang G. P., Grundke-Iqbal I., Kascsak R. J., Iqbal K., Wisniewski H. M. Alzheimer neurofibrillary tangles: monoclonal antibodies to inherent antigen(s). Acta Neuropathol. (Berlin) 1984; 62: 268
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I., Wang G. P., Tung Y. C., Wisniewski H. M. Alzheimer paired helical filaments: identification of polypeptides with monoclonal antibodies. Acta Neuropathol. 1985; 68: 279
   PubMed Web of Science ®Google Scholar
• Brion J. P., Couck A. M., Passareiro E., Flament-Durand J. Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. J. Submicrosc. Cytol. 1985; 17: 89
   PubMedGoogle Scholar
• Yen S. H., Crowe A., Dickson D. W. Monoclonal antibodies to Alzheimer neurofibrillary tangles. I. Identification of polypeptides. Am. J. Pathol. 1985; 120: 282
   PubMed Web of Science ®Google Scholar
• Dickson D. W., Kress Y., Crowe A., Yen S. H. Monoclonal antibodies to Alzheimer neurofibrillary tangles. II. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. Am. J. Pathol. 1985; 120: 292
   PubMed Web of Science ®Google Scholar
• Gambetti P., Shecket G., Ghetti B., Hirano A., Dahl D. Neurofibrillary changes in human brain: an immunocytochemical study with a neurofilament antiserum. J. Neuropathol. Exp. Neurol. 1983; 42: 69
   PubMed Web of Science ®Google Scholar
• Gambetti P., Autilio-Gambetti L., Perry G., Shecket G., Crane R. C. Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions. Lab. Invest. 1983; 49: 430
   PubMed Web of Science ®Google Scholar
• Perry G., Rizzuto N., Autilio-Gambetti L., Gambetti P. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 3916
   PubMed Web of Science ®Google Scholar
• Dahl D., Selkoe D. J., Pero R. T., Bignami A. Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum. J. Neurosci. 1982; 2: 113
   PubMed Web of Science ®Google Scholar
• Rasool C. G., Selkoe D. J. Alzheimer's disease: exposure of neurofilament immunoreactivity in SDS-insoluble paired helical filaments. Brain Res. 1984; 322: 194
   PubMed Web of Science ®Google Scholar
• Rasool C. G., Abraham C., Anderton B. H., Haugh M., Kahn J., Seikoe D. J. Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies. Brain Res. 1984; 310: 249
   PubMed Web of Science ®Google Scholar
• Kosik K. S., Duffy L. K., Dowling M. M., Abraham C., McCluskey A., Seikoe D. J. Microtubule-associated protein-2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer's neurofibrillary tangles. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 7941
   PubMed Web of Science ®Google Scholar
• Iqbal K., Zaidi T., Thompson C. H., Merz P. A., Wisniewski H. M. Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol. (Berlin) 1984; 62: 167
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I., Iqbal K., Tung Y. C., Wisniewski H. M. Alzheimer paired helical filaments: immunochemical identification of polypeptides. Acta Neuropathol. (Berlin) 1984; 62: 259
   PubMed Web of Science ®Google Scholar
• Nakazato Y., Sasaki A., Hirato J., Ishida Y. Immunohistochemical localization of neurofilament protein in neuronal degenerations. Acta Neuropathol. (Berlin) 1984; 64: 30
   PubMed Web of Science ®Google Scholar
• Bignami A., Selkoe D. J., Dahl D. Amyloid-like (congophilic) neurofibrillary tangles do not react with neurofilament antisera in Alzheimer's cerebral cortex. Acta Neuropathol. (Berlin) 1984; 64: 243
   PubMed Web of Science ®Google Scholar
• Wills M. R., Savory J. Aluminum poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet 1983; 2: 29
   PubMed Web of Science ®Google Scholar
• Savory J., Bertholf R. L., Wills M. R. Aluminum toxicity in chronic renal insufficiency. Clin. Endocrinol. Metab. 1985; 14: 681
   PubMedGoogle Scholar
• Sjogren B., Lundberg I., Lidums V. Aluminum in the blood and urine of industrially exposed workers. Br. J. Ind. Med. 1983; 40: 301
   PubMedGoogle Scholar
• Theriault G., Gingras S., Provencher S. Telangiectasia in aluminum workers: a follow up. Br. J. Ind. Med. 1984; 41: 367
   PubMedGoogle Scholar
• Feild G. B. Pulmonary function in aluminum smelters. Thorax 1984; 39: 743
   PubMed Web of Science ®Google Scholar
• Mussi I., Calzaferri G., Buratti M., Alessio L. Behavior of plasma and urinary aluminum levels in occupationally exposed subjects. Int. Arch. Occup Environ. Health 1984; 54: 155
   PubMed Web of Science ®Google Scholar
• Berlyne G. M., Ben-Air J., Pest D., Weinberger J., Stern M., Gilmore G. R., Levine R. Hyperaluminaemia from aluminum resins in renal failure. Lancet 1970; 494
   PubMedGoogle Scholar
• Ulmer D. D. Toxicity from aluminum antacids. N. Engl. J. Med. 1976; 294: 4, 218
   PubMed Web of Science ®Google Scholar
• Cannata J. B., Briggs J. D., Junor B. J. R., Fell G. S. Aluminum hydroxide intake: real risk of aluminum toxicity. Br. Med. J. 1983; 286: 1937
   PubMed Web of Science ®Google Scholar
• Knoll O., Kellinghaus H., Bertram H. P., Zumkley H., Graefe U. Gastrointestinal absorption of aluminum in chronic renal insufficiency. Contr. Nephrol 1984; 38: 24
   PubMedGoogle Scholar
• Bertholf R. L., Roman J. M., Brown S., Savory J., Wills M. R. Aluminum hydroxide-induced osteomalacia, encephalopathy, and hyperaluminemia in CAPD. Treatment with desferrioxamine. Periton. Dial. Bull. 1984; 4: 30
   Google Scholar
• Klatzo I., Wisniewski H., Streicher E. Experimental production of neurofibrillary degeneration. 1. Light microscopic observations. J. Neuropathol. Exp. Neurol. 1965; 24: 187
   PubMed Web of Science ®Google Scholar
• Terry R. D., Pena C. Experimental production of neurofibrillary degeneration. II. Electron microscopy, phosphatase histochemistry, and electron microprobe analysis. J. Neuropathol. Exp. Neurol. 1965; 24: 200
   PubMed Web of Science ®Google Scholar
• Wisniewski H., Narkiewicz O., Wisniewska K. Topography and dynamics of neurofibrillary degeneration in aluminum enceophalopathy. Acta Neuropathol. 1967; 9: 127
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Tomko G. J. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration. Brain Res. 1975; 97: 253
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M., Sturman J. A., Shek J. W. Aluminum chloride induced neurofibrillary changes in the developing rabbit: a chronic animal model. Ann. Neurol. 1980; 8(5)479
   PubMed Web of Science ®Google Scholar
• Yates C. M., Gordon A., Wilson H. Neurofibrillary degeneration induced in the rabbit by aluminum chloride: aluminum neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 1976; 2: 131
   Web of Science ®Google Scholar
• Wisniewski H. M., Sturman J. A., Shek J. W. Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum. Neurobiol. Aging 1982; 3: 11
   PubMed Web of Science ®Google Scholar
• Seil F. J., Lampert P. W., Klatzo I. Neurofibrillary spheroids induced by aluminum phosphate in dorsal root ganglia neurons in vitro. J. Neuropathol. Exp. Neurol. 1969; 28: 74
   PubMed Web of Science ®Google Scholar
• Miller C. A., Levine E. M. Effects of aluminum salts on cultured neuroblastoma cells. J. Neurochem. 1974; 22: 751
   PubMed Web of Science ®Google Scholar
• Cole G. M., Wu K., Timiras P. S. A culture model for age-related human neurofibrillary pathology. Int. J. Dev. Neurosci. 1985; 3: 23
   PubMed Web of Science ®Google Scholar
• Seil F. J., Lampert P. W. Neurofibrillary tangles induced by vincristine and vinblastine sulfate in central and peripheral neurons in vitro. Exp. Neurol. 1968; 21: 219
   PubMed Web of Science ®Google Scholar
• Seikoe D. J., Liem R. K. H., Yen S., Shelanski M. L. Biochemical and immunological characterization of neurofilaments in experimental neurofibrillary degeneration induced by aluminum. Brain Res. 1979; 163: 235
   PubMed Web of Science ®Google Scholar
• Ghetti B., Gambetti P. Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies. Brain Res. 1983; 276: 388
   PubMed Web of Science ®Google Scholar
• Troncoso J. C., Price D. L., Griffin J. W., Parhad I. M. Neurofibrillary axonal pathology in aluminum intoxication. Ann. Neurol. 1982; 12: 278
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M., Shek J. W., Gruca S., Sturman J. A. Aluminum-induced neurofibrillary changes in axons and dendrites. Acta Neuropathol. (Berlin) 1984; 63: 190
   PubMed Web of Science ®Google Scholar
• Uemura E. Intranuclear aluminum accumulation in chronic animals with experimental neurofibrillary changes. Exp. Neurol. 1984; 85: 10
   PubMed Web of Science ®Google Scholar
• Uemura E., Ireland W. P. Synaptic density in chronic animals with experimental neurofibrillary changes. Exp. Neurol. 1984; 85: 1
   PubMed Web of Science ®Google Scholar
• Ghetti B., Musieco M., Norton J., Bugiani O. Nerve cell loss in the progressive encephalopathy induced by aluminum powder. A morphologic and semiquantitative study of the purkinje cells. Neuropathol. Appl. Neurobiol. 1985; 11: 31
   PubMed Web of Science ®Google Scholar
• Simpson J., Yates C. M., Whyler D. K., Wilson H., Dewar A. J., Gordon A. Biochemical studies on rabbits with aluminum induced neurofilament accumulations. Neurochem. Res. 1985; 10: 229
   PubMed Web of Science ®Google Scholar
• Exss R. E., Summer G. K. Basic proteins in neurons containing fibrillary deposits. Brian Res. 1973; 49: 151
   PubMed Web of Science ®Google Scholar
• Magour S., Maser H. Effect of acute treatment with aluminum chloride on brain microsomal protein synthesis of immature rats. Biochem. Soc. Trans. 1981; 9: 100
   PubMedGoogle Scholar
• DeBoni U., Crapper D. R. Paired helical filaments of the Alzheimer's type in cultured neurones. Nature (London) 1978; 271: 566
   PubMed Web of Science ®Google Scholar
• Arieff A. I., Cooper J. D., Armstrong D., Lazarowitz V. C. Dementia, renal failure, and brain aluminum. Ann. Int. Med. 1979; 90: 741
   PubMed Web of Science ®Google Scholar
• Kogeorgos J., Scholtz C. Neurofibrillary tangles in aluminum encephalopathy: a new finding. Neuropathol. Appl. Neurobiol 1982; 8: 246
   Web of Science ®Google Scholar
• Alfrey A. C. Dialysis enceophalopathy syndrome. Ann. Rev. Med. 1978; 29: 93
   PubMed Web of Science ®Google Scholar
• Velasco M., Velasco F., Pacheco M. T., Azpeitia E., Saldivar L., Estrada-Villanueva F. Alumina cream-induced focal motor epilepsy in cats. V. Exicision and transplant of the epileptogenic granuloma. Epilepsia 1984; 25: 752
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Dalton A. J. Alterations in short term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration. Physiol. Behav. 1973; 10: 925
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Dalton A. J. Aluminum induced neurofibrillary degeneration, brain electrical activity, and alterations in acquisition and retention. Physiol. Behav. 1973; 10: 935
   PubMed Web of Science ®Google Scholar
• King G. A., DeBoni U., Crapper D. R. Effect of aluminum upon conditioned avoidance response acquisition in the absence of neurofibrillary degeneration. Pharmacol. Biochem. Behav. 1975; 3: 1003
   PubMed Web of Science ®Google Scholar
• Cutrufo C., Caroli S., Delle Femmine P., Ortolani E., Palazzesi S., Violante N., Zapponi G. A., Loizzo A. Experimental aluminum encephalopathy: quantitative EEG analysis of aluminum bioavailability. J. Neurol. Neurosurg. Psychiatr. 1984; 47: 204
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Krishnan S. S., Dalton A. J. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 1973; 180: 511
   PubMed Web of Science ®Google Scholar
• Petit T. L., Biederman G. B., McMullen P. A. Neurofibrillary degeneration, denritic dying back, and learning-memory deficits after aluminum administration: implications for brain aging. Exp. Neurol. 1980; 67: 152
   PubMed Web of Science ®Google Scholar
• Rabe A., Lee M. H., Shek J., Wisniewski H. M. Learning deficit in immature rabbits with aluminum-induced neurofibrillary changes. Exp. Neurol. 1982; 76: 441
   PubMed Web of Science ®Google Scholar
• Bowdler N. C., Beasley D. S., Fritze E. C., Goulette A. M., Hatton J. D., Hession J., Ostman D. L., Rugg D. J., Schmittdiel C. J. Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol. Biochem. Behav. 1979; 10(4)505
   PubMed Web of Science ®Google Scholar
• Bertholf R. L., Brown S., Renoe B. W., Wills M. R., Savory J. Improved determination of aluminum in serum by electrothermal atomic absorption spectrometry. Clin. Chem. 1983; 29(6)1087
   PubMed Web of Science ®Google Scholar
• Brown S., Bertholf R. L., Wills M. R., Savory J. Electrothermal atomic absorption spectrometric determination of aluminum in serum using a new protein precipitation technique. 1984; 30: 1216
   Google Scholar
• Savory J., Berlin A., Courtoux C., Yeoman B., Wills M. R. Summary report of an international workshop on the role of biological monitoring in the prevention of aluminum toxicity in man — aluminum analysis in biological fluids. Ann. Clin. Lab. Sci. 1983; 13(5)444
   Web of Science ®Google Scholar
• McDermott J. R., Smith A. I., Iqbal K., Wisniewski M. M. Aluminum and Alzheimer's disease. Lancet 1977; 710
   PubMedGoogle Scholar
• McLachlan Crapper D. R., Krishnan S. S., Quittkat S., DeBoni U. Brain Aluminum in Alzheimer's Disease: Influence of Sample Size and Case Selection in Aluminum Neurotoxicity, L. Liss. Pathtox, Park Forest South, III. 1980; 25
   Google Scholar
• Crapper D. R., Krishnan S. S., Quittkat S. Aluminum, neurofibrillary degeneration, and Alzheimer's disease. Brain 1976; 99: 67
   PubMed Web of Science ®Google Scholar
• Trapp G. A., Miner G. D., Zimmerman R. L., Mastri A. R., Heston L. L. Aluminum levels in brain in Alzheimer's disease. Biol. Psychr. 1978; 13(6)709
   PubMed Web of Science ®Google Scholar
• Crapper D. R., Quittkat S., Krishnan S. S., Dalton A. J., DeBoni U. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathol. 1980; 50: 19
   PubMed Web of Science ®Google Scholar
• DeBoni U., Scott J. W., Crapper D. R. Intracellular aluminum binding; a histochemical study. Histochemistry 1974; 40: 31
   PubMedGoogle Scholar
• Perl D. P., Brody A. R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 1980; 208: 297
   PubMed Web of Science ®Google Scholar
• Candy J. M., Oakley A. E., Klinowski J., Carpenter T. A., Perry R. H., Atack J. R., Perry E. K., Blessed G., Fairbairn A., Edwardson J. A. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet 1986; 1: 354
   PubMed Web of Science ®Google Scholar
• Garruto R. M., Fukatsu R., Yanagihara R., Gajdusek D. C., Hook G., Fiori C. E. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in Parkinsonism-dementia of Guam. Proc. Natl. Acad. Set. U.S.A. 1984; 81: 1875
   PubMed Web of Science ®Google Scholar
• Mayor G. H., Keiser J. A., Makdani D., Ku P. K. Aluminum absorption and distribution: effect of parathyroid hormone. Science 1977; 197: 1187
   PubMed Web of Science ®Google Scholar
• Biswas C. K., Arze R. S., Ramos J. M., Ward M. K., Dewar J. H., Kerr D. N., Kenward D. H. Effect of aluminum hydroxide on serum ionized calcium, immunoreactive parathyroid hormone, and aluminum in chronic renal failure. Br. Med J 1982; 284: 776
   PubMedGoogle Scholar
• Burnatowska-Hledin M. A., Kaiser L., Mayor G. H. Aluminum parathyroid hormone, and osteomalacia. Spec. Top. Endocrinol Metab 1983; 5: 201
   PubMedGoogle Scholar
• Shore D., Wyatt R. J. Research design issues: antialuminum drug studies in Alzheimer's disease. Clin. Neuropkarmacol. 1982; 5(4)337
   PubMed Web of Science ®Google Scholar
• Cardelli M. B., Russell M., Bagne C. A., Pomara N. Chelation therapy: unproved modality in the treatment of Alzheimer-type dementia. J. Am. Geriatr. Soc 1985; 33: 548
   PubMed Web of Science ®Google Scholar
• Ackrill P., Ralston A. J., Day J. P., Hodge K. C. Successful removal of aluminum from patient with dialysis encephalopathy. Lancet 1980; 692
   PubMed Web of Science ®Google Scholar
• Williams P., Khanna R., McLachlan Crapper D. R. Enhancement of aluminum removal by desferoxamine in a patient on continuous ambulatory peritoneal dialysis with dementia. Periton. Dial. Bull. 1981; 1(5)73
   Google Scholar
• Arze R. S., Parkinson I. S., Cartlidge N. E. F., Britton P., Ward M. K. Reversal of aluminum dialysis encephalopathy after desferrioxamine treatment. Lancet 1981; 2: 1116
   PubMed Web of Science ®Google Scholar
• Kesner R. P. Correspondence between humans and animals in coping of temporal attributes: roll of hippocampus and prefrontal cortex. Ann. N.Y Acad. Sci. 1985; 444: 122
   PubMed Web of Science ®Google Scholar
• Olton D. S. Strategies for the development of animal models of human memory impairments. Ann. N.Y. Acad. Sci. 1985; 444: 113
   PubMed Web of Science ®Google Scholar
• Arnsten A. F. T., Goldman-Rakic P. S. Catecholamines and cognitive decline in aged nonhuman primates. Ann. N.Y. Acad. Sci. 1985; 218
   PubMed Web of Science ®Google Scholar
• Schwartz J. H. Axonal transport: components, mechanisms, and specificity. Ann. Rev. Neurosci. 1979; 2: 467
   PubMed Web of Science ®Google Scholar
• Liwnicz B. H., Kristensson K., Wisniewski H. M., Shelanski M. L., Terry R. D. Observations on axoplasmic transport in rabbits with aluminum-induced neurofibrillary tangles. Brain Res. 1974; 80: 413
   PubMed Web of Science ®Google Scholar
• Bonhaus D. W., McCormack K. M., Mayor G. H., Mattson J. C., Hook J. B. The effects of aluminum on microtubular integrity using in vitro and in vivo models. Toxicol. Lett. 1980; 6: 141
   PubMed Web of Science ®Google Scholar
• Bizzi A., Crane R., Autillo-Gambetti L., Gambetti P. Aluminum effect on slow axonal transport; a novel impairment of neurofilament transport. J. Neurosci. 1984; 4: 722
   PubMed Web of Science ®Google Scholar
• Troncoso J. C., Hoffman P. N., Griffin J. W., Hess-Kozlow K. M., Price D. L. Aluminum intoxication: a disorder of neurofilament transport in motor neurons. Brain Res. 1985; 342: 172
   PubMed Web of Science ®Google Scholar
• Kosik K. S., McCluskey A. H., Walsh F. X., Selkoe D. J. Axonal transport of cytoskeletal proteins in aluminum toxicity. Neurochem. Pathol. 1985; 3: 99
   PubMedGoogle Scholar
• Gadjdusek D. C. Hypothesis: interference with axonal transport of neurofilament as a common pathogenic mechanism in certain diseases of the centra) nervous system. N. Engl. J. Med. 1985; 312: 714
   PubMed Web of Science ®Google Scholar
• Munoz-Garcia D., Ludwin S. K. Classical and generalized variants of Pick's disease: a clinico-pathological, ultrastructural, and immunocytoehemical comparative study. Ann. Neurol. 1984; 16: 467
   PubMed Web of Science ®Google Scholar
• Rasool C. G., Selkoe D. J. Sharing of specific antigens by degenerating neurons in Pick's disease and Alzheimer's disease. N. Engl. J. Med. 1985; 312: 700
   PubMed Web of Science ®Google Scholar
• Kahn J., Anderton B. H., Gibb W. R. G., Lees A. J., Wells F. R., Marsden C. D. Neuronal filaments in Alzheimer's, Pick's, and Parkinson's disease. N. Engl. J. Med. 1985; 313: 520
   PubMedGoogle Scholar
• Ashford J. W., Jarvik L. Alzheimer's disease: does neuron plasticity predispose to axonal neurofibrillary degeneration?. N. Engl. J. Med. 1985; 313: 388
   PubMed Web of Science ®Google Scholar
• Caceres A., Banker G. A., Binder L. Immunocytochemical localization of tubulin and microtubule-associated protein 2 during the development of hippocampal neurons in culture. J. Neurosci. 1986; 6: 714
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I., Iqbal K., Quinlan M., Tung T. C., Zaidi M. S., Wisniewski H. M. Microtubule-associated protein tau: a component of Alzheimer paired helical filaments. J. Biol. Chem. 1986; 261: 6084
   PubMed Web of Science ®Google Scholar
• Wood J. G., Mirra S. S., Pollock N. J., Binder L. I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (T). Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 4040
   PubMed Web of Science ®Google Scholar
• Kosik K. S., Joachim C. L., Selkoe D. J. Microtubule-associated protein tau (T) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 4044
   PubMed Web of Science ®Google Scholar
• Iqbal K., Grundke-Iqbal I., Zaidi T., Merz P. A., Wen G. Y., Shaikn S. S., Wisniewski H. M. Defective brain microtubule assembly in Alzheimer's disease. Lancet 1986; 2: 421
   PubMed Web of Science ®Google Scholar
• Sternberger L. A., Sternberger N. H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments, in situ. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 6126
   PubMed Web of Science ®Google Scholar
• Sternberger N. H., Sternberger L. A., Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 4274
   PubMed Web of Science ®Google Scholar
• Cork L. C., Sternberger N. H., Sternberger L. A., Casanova M. F., Struble R. G., Price D. L. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 1986; 45: 56
   PubMed Web of Science ®Google Scholar
• Troncoso J. C., Sternberger N. H., Sternberger L. A., Heffman P. N., Price D. L. Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum. Brain Res. 1986; 364: 295
   PubMed Web of Science ®Google Scholar
• Bizzi A., Gambetti P. Phosphorylation of neurofilaments is altered in aluminum intoxication. Acta Neuropathol. 1986; 71: 154
   PubMed Web of Science ®Google Scholar
• Munoz-Garcia D., Pendlebury W. W., Kessler J. B., Perl D. P. An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol. 1986; 70: 243
   PubMed Web of Science ®Google Scholar
• Martin R. B. The chemistry of aluminum as related to biology and medicine. Clin. Chem. 1986; 32: 1797
   PubMed Web of Science ®Google Scholar
• MacDonald T. L., Humphreys W. G., Martin R. B. Promotion of tubulin assembly by aluminum ion. Science 1987; 236: 183
   PubMed Web of Science ®Google Scholar